I started working with scientists in 1985 when I took a position at The Salk Institute for Biological Studies as administrative assistant to Dr. Roger Guillemin, Nobel laureate. I worked with both the chemistry and biology scientists, submitting grant applications, editing and submitting manuscripts, and preparing presentations and posters for submission at scientific meetings. When our laboratories relocated to The Whittier Institute for Diabetes and Endocrinology, I took over the responsibility of managing Dr. Guillemin’s Program Project Grant, an enormously complex and time-consuming task in those days of paper copies and typewritten form pages. Photograph figures had to be printed professionally and secured into each bound copy of the 200-page grant application. Things have certainly become streamlined in 35 years. In 1994, Dr. Douglas Lappi and I co-founded Advanced Targeting Systems to offer saporin conjugates to scientists around the world. We raised funds for the development of SP-SAP as a chronic pain therapeutic. I coordinated meetings with the FDA and CVM to discuss clinical and veterinary trials and oversaw the first human clinical trial at the University of Texas, SW with Dr. Arthur Frankel as the sponsoring physician. When Dr. Lappi retired in 2016, I assumed the role of President of Advanced Targeting Systems. Since 1994, we have provided saporin conjugates and other targeting tools to scientists in both academic and biotechnology organizations.